Hui‐Chuan Sun

机构：Sun Yat-sen University, Jilin University, Fudan University, Zhongshan Hospital, The First Affiliated Hospital, Sun Yat-sen University, Ministry of Education · ORCID：0000-0003-3761-7058

发表论文 516 篇 · 总被引 22770 次 · h-index 76

代表论文

• The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment (2025 · The Lancet · 被引 162)
• China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition) (2025 · Liver Cancer · 被引 41)
• Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study (2025 · The Lancet Oncology · 被引 20)
• Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma (2025 · Gut · 被引 10)
• Structural characterization of five functional states of metabotropic glutamate receptor 8 (2025 · Molecular Cell · 被引 8)
• First-line tislelizumab and ociperlimab combined with gemcitabine and cisplatin in advanced biliary tract cancer (ZSAB-TOP): a multicenter, single-arm, phase 2 study (2025 · Signal Transduction and Targeted Therapy · 被引 8)